<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37561325</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-4978</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Molecular biology reports</Title><ISOAbbreviation>Mol Biol Rep</ISOAbbreviation></Journal><ArticleTitle>Association of angiotensin-converting enzyme (ACE) I/D variation with biochemical parameters and oxidative stress markers in systemic lupus erythematosus patients in west of Iran.</ArticleTitle><Pagination><StartPage>8201</StartPage><EndPage>8212</EndPage><MedlinePgn>8201-8212</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11033-023-08685-x</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">We aimed to study insertion/deletion (I/D) variation (rs4646994) of ACE gene in a group of SLE patients in west of Iran and its possible relationship with oxidative stress.</AbstractText><AbstractText Label="METHOD AND RESULTS" NlmCategory="RESULTS">Genotypes and allele frequencies related to ACE (I/D) variation were determined in 108 SLE patients and 110 gender and age-matched healthy controls using PCR. Neopterin, malondialdehyde (MDA), and serum lipid concentrations were determined by HPLC and enzyme assay respectively. The overall distribution of ACE I/D genotypes in SLE patients was different from that of the control group (P&#x2009;=&#x2009;0.005). DD genotype compared to ID genotype increased the risk of SLE (OR&#x2009;=&#x2009;2.57, 95% CI 1.4-4.8, P&#x2009;=&#x2009;0.003). ID genotype compared to the II genotype decreased the risk of disease (OR&#x2009;=&#x2009;0.45, 95% CI 0.2-0.99, p&#x2009;=&#x2009;0.042). SLE patients with DD, ID, and II genotypes had lower paraoxonase (PON) activity and higher serum levels of MDA and neopterin versus control patients. We also detected a significant protective effect against SLE in presence of ACE I alleles and lack of angiotensin II receptor, type 1 (AGTR1) A1166C (NCBI reference SNP id: rs5186), C alleles in this study (OR&#x2009;=&#x2009;0.31, 95% CI 0.14-0.68, P&#x2009;=&#x2009;0.002).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Carriers of the DD genotype of ACE gene with higher serum concentrations of neopterin and MDA, and lower PON activity had a high risk to develop SLE, while ID genotype decreased the risk of disease development by 2.22 times compared to II genotype.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kiani</LastName><ForeName>Amir</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7802-2117</Identifier><AffiliationInfo><Affiliation>Regenerative Medicine Research Center (RMRC), Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elieh-Ali-Komi</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-0546-5280</Identifier><AffiliationInfo><Affiliation>Institute of Allergology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t Zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahrehmand</LastName><ForeName>Fariborz</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3866-6847</Identifier><AffiliationInfo><Affiliation>Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mostafaei</LastName><ForeName>Shayan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1966-1306</Identifier><AffiliationInfo><Affiliation>Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaisi-Raygani</LastName><ForeName>Asad</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3042-2832</Identifier><AffiliationInfo><Affiliation>Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. avaisiraygani@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baniamerian</LastName><ForeName>Hosein</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-8214-3990</Identifier><AffiliationInfo><Affiliation>Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. hosseinbani@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aghaz</LastName><ForeName>Farank</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7311-4071</Identifier><AffiliationInfo><Affiliation>Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanhapour</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3098-9564</Identifier><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shakiba</LastName><ForeName>Ebrahim</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9603-4293</Identifier><AffiliationInfo><Affiliation>Behavioral Disease Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahimi</LastName><ForeName>Zohreh</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-7589-3307</Identifier><AffiliationInfo><Affiliation>Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pourmotabbed</LastName><ForeName>Tayebeh</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3468-5880</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol Biol Rep</MedlineTA><NlmUniqueID>0403234</NlmUniqueID><ISSNLinking>0301-4851</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000809">Angiotensins</NameOfSubstance></Chemical><Chemical><RegistryNumber>670-65-5</RegistryNumber><NameOfSubstance UI="D019798">Neopterin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.15.1</RegistryNumber><NameOfSubstance UI="D007703">Peptidyl-Dipeptidase A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.15.1</RegistryNumber><NameOfSubstance UI="C488034">ACE protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000809" MajorTopicYN="N">Angiotensins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019798" MajorTopicYN="N">Neopterin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007703" MajorTopicYN="N">Peptidyl-Dipeptidase A</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE gene insertion/deletion (I/D) variation</Keyword><Keyword MajorTopicYN="N">Angiotensin-converting enzyme</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">rs13447447</Keyword><Keyword MajorTopicYN="N">rs1799752</Keyword><Keyword MajorTopicYN="N">rs4340</Keyword><Keyword MajorTopicYN="N">rs4646994</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>26</Day><Hour>13</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37561325</ArticleId><ArticleId IdType="doi">10.1007/s11033-023-08685-x</ArticleId><ArticleId IdType="pii">10.1007/s11033-023-08685-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fava A, Petri M (2019) Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun 96:1&#x2013;13. https://doi.org/10.1016/j.jaut.2018.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.11.001</ArticleId><ArticleId IdType="pubmed">30448290</ArticleId></ArticleIdList></Reference><Reference><Citation>Nusbaum JS, Mirza I, Shum J, Freilich RW, Cohen RE, Pillinger MH et al (2020) Sex differences in systemic lupus erythematosus: epidemiology, clinical considerations, and disease pathogenesis. Mayo Clin Proc 95(2):384&#x2013;394. https://doi.org/10.1016/j.mayocp.2019.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2019.09.012</ArticleId><ArticleId IdType="pubmed">32029091</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel GJ, Ugarte-Gil MF, Alarc&#xf3;n GS (2017) Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol 13(8):799&#x2013;814. https://doi.org/10.1080/1744666x.2017.1327352</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666x.2017.1327352</ArticleId><ArticleId IdType="pubmed">28471259</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L, Lu MP, Wang JH, Xu M, Yang SR (2020) Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr 16(1):19&#x2013;30. https://doi.org/10.1007/s12519-019-00229-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-019-00229-3</ArticleId><ArticleId IdType="pubmed">30796732</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortuna G, Brennan MT (2013) Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management. Dent Clin North Am 57(4):631&#x2013;655. https://doi.org/10.1016/j.cden.2013.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cden.2013.06.003</ArticleId><ArticleId IdType="pubmed">24034070</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y, Kuba K, Ohto-Nakanishi T, Penninger JM (2010) Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circ J 74(3):405&#x2013;410. https://doi.org/10.1253/circj.cj-10-0045</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.cj-10-0045</ArticleId><ArticleId IdType="pubmed">20134095</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah D, Mahajan N, Sah S, Nath SK, Paudyal B (2014) Oxidative stress and its biomarkers in systemic lupus erythematosus. J Biomed Sci 21(1):23. https://doi.org/10.1186/1423-0127-21-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-23</ArticleId><ArticleId IdType="pubmed">24636579</ArticleId><ArticleId IdType="pmc">3995422</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo Junior AF, Dalpiaz PLM, Escouto LDS, Sousa GJ, Aires R, Oliveira ND et al (2020) Involvement of sex hormones, oxidative stress, ACE and ACE2 activity in the impairment of renal function and remodelling in SHR. Life Sci 257:118138. https://doi.org/10.1016/j.lfs.2020.118138</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118138</ArticleId><ArticleId IdType="pubmed">32712298</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitipakorn U, Suwannalai P, Trachoo O, Rattanasiri S, Chitphuk S, Ngamjanyaporn P et al (2016) Angiotensin-converting enzyme gene polymorphism in Thai patients with systemic lupus erythematosus. Int J Rheum Dis 19(7):693&#x2013;699. https://doi.org/10.1111/1756-185x.12609</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185x.12609</ArticleId><ArticleId IdType="pubmed">26200015</ArticleId></ArticleIdList></Reference><Reference><Citation>Negi VS, Devaraju P, Gulati R (2015) Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism is not a risk factor for hypertension in SLE nephritis. Clin Rheumatol 34(9):1545&#x2013;1549. https://doi.org/10.1007/s10067-015-2954-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-015-2954-6</ArticleId><ArticleId IdType="pubmed">25957879</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, Dar SA, Mandal RK, Jawed A, Wahid M, Panda AK et al (2018) Angiotensin-converting enzyme gene I/D polymorphism is associated with systemic lupus erythematosus susceptibility: an updated meta-analysis and trial sequential analysis. Front Physiol 9:1793. https://doi.org/10.3389/fphys.2018.01793</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.01793</ArticleId><ArticleId IdType="pubmed">30618805</ArticleId><ArticleId IdType="pmc">6305102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickhah Z, Roudbordeh M, Asadi M, Ebrahimi P, Amoli M (2023) Association of ACE gene polymorphisms with in-stent restenosis by stent type (biomime, supraflex, xience). Mol Biol Rep. https://doi.org/10.1007/s11033-023-08554-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-023-08554-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Zmorzynski S, Szudy-Szczyrek A, Popek-Marciniec S, Korszen-Pilecka I, Wojcierowska-Litwin M, Luterek M et al (2019) ACE insertion/deletion polymorphism (rs4646994) is associated with the increased risk of multiple myeloma. Front Oncol. https://doi.org/10.3389/fonc.2019.00044</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2019.00044</ArticleId><ArticleId IdType="pubmed">31681592</ArticleId><ArticleId IdType="pmc">6798955</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs M, Lahousse L, Van Eeckhoutte HP, Wijnant SRA, Delanghe JR, Brusselle GG et al (2021) Effect of ACE1 polymorphism rs1799752 on protein levels of ACE2, the SARS-CoV-2 entry receptor, in alveolar lung epithelium. ERJ Open Res. https://doi.org/10.1183/23120541.00940-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00940-2020</ArticleId><ArticleId IdType="pubmed">33889638</ArticleId><ArticleId IdType="pmc">7917434</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez-Haro A, Valle Y, Valdes-Alvarado E, Casillas-Mu&#xf1;oz F, Mu&#xf1;oz-Valle JF, Reynoso-Villalpando GL et al (2017) Assessment of the rs4340 ACE gene polymorphism in acute coronary syndrome in a Western Mexican population. Genet Mol Res. https://doi.org/10.4238/gmr16039779</Citation><ArticleIdList><ArticleId IdType="doi">10.4238/gmr16039779</ArticleId><ArticleId IdType="pubmed">28973758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2006) Angiotensin-converting enzyme insertion/deletion polymorphism and systemic lupus erythematosus: a metaanalysis. J Rheumatol 33(4):698&#x2013;702</Citation><ArticleIdList><ArticleId IdType="pubmed">16583472</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanhapour M, Miri A, Vaisi-Raygani A, Bahrehmand F, Kiani A, Rahimi Z et al (2018) Synergism between apolipoprotein E &#x190;4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus. Clin Rheumatol 37(4):971&#x2013;977. https://doi.org/10.1007/s10067-017-3859-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-017-3859-3</ArticleId><ArticleId IdType="pubmed">29273831</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanhapour M, Vaisi-Raygani A, Bahrehmand F, Khazaei M, Kiani A, Rahimi Z et al (2016) Association between the cytotoxic T-lymphocyte antigen-4 mutations and the susceptibility to systemic lupus erythematosus; contribution markers of inflammation and oxidative stress. Cell Mol Biol (Noisy-le-Grand, France) 62(12):56&#x2013;61. https://doi.org/10.14715/cmb/2016.62.12.10</Citation><ArticleIdList><ArticleId IdType="doi">10.14715/cmb/2016.62.12.10</ArticleId></ArticleIdList></Reference><Reference><Citation>Elieh Ali Komi D, Rahimi Y, Asghari R, Jafari R, Rasouli J, Mohebalizadeh M et al (2021) Investigation of the molecular mechanism of coagulopathy in severe and critical patients with COVID-19. Front Immunol 12:762782. https://doi.org/10.3389/fimmu.2021.762782</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.762782</ArticleId><ArticleId IdType="pubmed">34975853</ArticleId><ArticleId IdType="pmc">8716500</ArticleId></ArticleIdList></Reference><Reference><Citation>Amirzargar A, Rey D, Mu&#xf1;iz E, Palacio-Gruber J, Nikbin B, Nicknam H et al (2015) Kurds HLA genes: its implications in transplantation and pharmacogenomics. Open Med 2:43&#x2013;47. https://doi.org/10.2174/1874220301401010043</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874220301401010043</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahrehmand F, Vaisi-Raygani A, Rahimi Z, Ahmadi R, Kiani A, Tavilani H et al (2014) Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report. Lupus 23(3):263&#x2013;272. https://doi.org/10.1177/0961203313518622</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313518622</ArticleId><ArticleId IdType="pubmed">24399815</ArticleId></ArticleIdList></Reference><Reference><Citation>Akai Y, Sato H, Iwano M, Kurumatani N, Kurioka H, Kubo A et al (1999) Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of lupus nephritis. Clin Nephrol 51(3):141&#x2013;146</Citation><ArticleIdList><ArticleId IdType="pubmed">10099886</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahrehmand F, Vaisi-Raygani A, Kiani A, Rahimi Z, Tavilani H, Navabi SJ et al (2012) Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients. Lupus 21(6):616&#x2013;624. https://doi.org/10.1177/0961203312436857</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203312436857</ArticleId><ArticleId IdType="pubmed">22323339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir H, Elieh Ali Komi D, Pouramir M, Parsian H, Moghadamnia AA, Seyfizadeh N et al (2021) The hepatoprotective effects of Pyrus biossieriana buhse leaf extract on tert-butyl hydroperoxide toxicity in HepG2 cell line. BMC Res Notes 14(1):298. https://doi.org/10.1186/s13104-021-05713-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-021-05713-6</ArticleId><ArticleId IdType="pubmed">34344447</ArticleId><ArticleId IdType="pmc">8336407</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafi K, Ahmadi S, Rahpeyma M, Khazaie H, Vaisi-Raygani A, Moini A et al (2017) Study of serum malondialdehyde level in opioid and methamphetamine dependent patients. Acta Med Iran 55(10):616&#x2013;620</Citation><ArticleIdList><ArticleId IdType="pubmed">29228526</ArticleId></ArticleIdList></Reference><Reference><Citation>Elieh Ali Komi D, Sadeghi-Shabestari M, Shanebandi D, Babaloo Z, Razavi A, Sadigh-Eteghad S et al (2019) Investigation of Chitinase3like-1 (Chiti3L1) gene polymorphism (rs4950928) with susceptibility to allergic asthma in Iranian northwestern Azeri population. Res Mol Med 7(4):17&#x2013;24. https://doi.org/10.32598/rmm.7.4.17</Citation><ArticleIdList><ArticleId IdType="doi">10.32598/rmm.7.4.17</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi-Noori E, Salehi N, Mozafari H, Elieh Ali Komi D, Saidi M, Bahrehmand F et al (2020) Association of AHSG gene polymorphisms with serum Fetuin-A levels in individuals with cardiovascular calcification in west of Iran. Mol Biol Rep 47(3):1809&#x2013;1820. https://doi.org/10.1007/s11033-020-05275-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05275-z</ArticleId><ArticleId IdType="pubmed">32002794</ArticleId></ArticleIdList></Reference><Reference><Citation>Beheiry M, Omer A, Abdallah A, Elhassan A, Ali I, Gasim E (2019) Association of insertion-deletion polymorphism in the angiotensin-converting enzyme gene and human essential hypertension among Sudanese in Al Nubba village. Saudi J Med. https://doi.org/10.21276/sjm.2019.4.1.11</Citation><ArticleIdList><ArticleId IdType="doi">10.21276/sjm.2019.4.1.11</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolli P, Sticchi E, Giusti B, Saracini C, Abbate R, Fatini C (2011) Improvement in ACE I/D polymorphism detection. J Renin Angiotensin Aldosterone syst 12(3):129&#x2013;132. https://doi.org/10.1177/1470320310381911</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320310381911</ArticleId><ArticleId IdType="pubmed">21059823</ArticleId></ArticleIdList></Reference><Reference><Citation>Borai I, Hassan N, Shaker O, Ashour E, Badrawy M, Fawzi O et al (2017) Synergistic effect of ACE and AGT genes in coronary artery disease. Beni-Suef Univ J Basic Appl Sci. https://doi.org/10.1016/j.bjbas.2017.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjbas.2017.09.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, Tsai JC (2002) ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25(6):1002&#x2013;1008. https://doi.org/10.2337/diacare.25.6.1002</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.25.6.1002</ArticleId><ArticleId IdType="pubmed">12032106</ArticleId></ArticleIdList></Reference><Reference><Citation>Baniamerian H, Bahrehmand F, Vaisi-Raygani A, Rahimi Z, Pourmotabbed T (2017) Angiotensin type 1 receptor A1166C polymorphism and systemic lupus erythematosus: correlation with cellular immunity and oxidative stress markers. Lupus 26(14):1534&#x2013;1539. https://doi.org/10.1177/0961203317711008</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317711008</ArticleId><ArticleId IdType="pubmed">28530466</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprovieri SR, Sens YA (2005) Polymorphisms of the renin-angiotensin system genes in Brazilian patients with lupus nephropathy. Lupus 14(5):356&#x2013;362. https://doi.org/10.1191/0961203305lu2093oa</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203305lu2093oa</ArticleId><ArticleId IdType="pubmed">15934435</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Investig 86(4):1343&#x2013;1346. https://doi.org/10.1172/jci114844</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci114844</ArticleId><ArticleId IdType="pubmed">1976655</ArticleId><ArticleId IdType="pmc">296868</ArticleId></ArticleIdList></Reference><Reference><Citation>Dur&#xe1;n-Barrag&#xe1;n S, McGwin G Jr, Vil&#xe1; LM, Reveille JD, Alarc&#xf3;n GS (2008) Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus&#x2013;results from LUMINA (LIX): a multiethnic US cohort. Rheumatology (Oxford) 47(7):1093&#x2013;1096. https://doi.org/10.1093/rheumatology/ken208</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken208</ArticleId><ArticleId IdType="pubmed">18511474</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman KM, Kelly J, Gray-McGuire C, Asundi N, Yu H, Reid J et al (2001) Linkage analysis of angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and systemic lupus erythematosus. Mol Cell Endocrinol 177(1&#x2013;2):81&#x2013;85. https://doi.org/10.1016/s0303-7207(01)00424-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0303-7207(01)00424-5</ArticleId><ArticleId IdType="pubmed">11377823</ArticleId></ArticleIdList></Reference><Reference><Citation>Prkacin I, Novak B, Serti&#x107; J, Mrzljak A (2001) Angiotensin-converting enzyme gene polymorphism in patients with systemic lupus. Acta Medica Croatica 55(2):73&#x2013;76</Citation><ArticleIdList><ArticleId IdType="pubmed">11505631</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassiulas IO, Aksentijevich I, Salmon JE, Kim Y, Yarboro CH, Vaughan EM et al (1998) Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patients. Clin Nephrol 50(1):8&#x2013;13</Citation><ArticleIdList><ArticleId IdType="pubmed">9710341</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsa A, Peden E, Lum RF, Seligman VA, Olson JL, Li H et al (2002) Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: analysis of 644 SLE families. Genes Immun 3(Suppl 1):S42-46. https://doi.org/10.1038/sj.gene.6363907</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6363907</ArticleId><ArticleId IdType="pubmed">12215901</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullmann R Jr (2003) Angiotensin-converting enzyme insertion/deletion polymorphism and vascular impairment in SLE. Lupus 12(2):147&#x2013;148. https://doi.org/10.1191/0961203303lu342xx</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203303lu342xx</ArticleId><ArticleId IdType="pubmed">12630762</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhm WS, Lee HS, Chung YH, Kim TH, Bae SC, Joo KB et al (2002) Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE. Lupus 11(4):227&#x2013;233. https://doi.org/10.1191/0961203302lu174oa</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203302lu174oa</ArticleId><ArticleId IdType="pubmed">12043886</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas G, Reilly C, Dooley MA, Page G, Cooper G, Gilkeson G (2004) Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus. J Rheumatol 31(9):1756&#x2013;1762</Citation><ArticleIdList><ArticleId IdType="pubmed">15338496</ArticleId></ArticleIdList></Reference><Reference><Citation>Molad Y, Gal E, Magal N, Sulkes J, Mukamel M, Weinberger A et al (2000) Renal outcome and vascular morbidity in systemic lupus erythematosus (SLE): lack of association with the angiotensin-converting enzyme gene polymorphism. Semin Arthritis Rheum 30(2):132&#x2013;137. https://doi.org/10.1053/sarh.2000.8365</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/sarh.2000.8365</ArticleId><ArticleId IdType="pubmed">11071585</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas D, Ezzat Y, Hamdy E, Gamil M (2012) Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus. Lupus 21(1):103&#x2013;110. https://doi.org/10.1177/0961203311418268</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203311418268</ArticleId><ArticleId IdType="pubmed">21976404</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain N, Jaffery G (2013) Distribution of human leukocyte antigen alleles in systemic lupus erythematosus patients with angiotensin converting enzyme insertion/deletion polymorphism. Bosn J Basic Med Sci 13(1):57&#x2013;62. https://doi.org/10.17305/bjbms.2013.2420</Citation><ArticleIdList><ArticleId IdType="doi">10.17305/bjbms.2013.2420</ArticleId><ArticleId IdType="pubmed">23448612</ArticleId><ArticleId IdType="pmc">4333918</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong AM, Li XY, Wang YQ, Yan HX, Xu ZX, Feng Z et al (2012) Association study of ACE polymorphisms and systemic lupus erythematosus in Northern Chinese Han population. Mol Biol Rep 39(10):9485&#x2013;9491. https://doi.org/10.1007/s11033-012-1813-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-012-1813-7</ArticleId><ArticleId IdType="pubmed">22729880</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato H, Akai Y, Iwano M, Kurumatani N, Kurioka H, Kubo A et al (1998) Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of systemic lupus erythematosus. Lupus 7(8):530&#x2013;534. https://doi.org/10.1191/096120398678920622</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120398678920622</ArticleId><ArticleId IdType="pubmed">9863894</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirabdaly S, Elieh Ali Komi D, Shakiba Y, Moini A, Kiani A (2020) Effects of temozolomide on U87MG glioblastoma cell expression of CXCR4, MMP2, MMP9, VEGF, anti-proliferatory cytotoxic and apoptotic properties. Mol Biol Rep 47(2):1187&#x2013;1197. https://doi.org/10.1007/s11033-019-05219-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-019-05219-2</ArticleId><ArticleId IdType="pubmed">31897867</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Svenungsson E, Gunnarsson I, Andersson B, Lundberg I, Sch&#xe4;fer Elinder L et al (1999) Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE. Lupus 8(2):142&#x2013;150. https://doi.org/10.1191/096120399678847434</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120399678847434</ArticleId><ArticleId IdType="pubmed">10192509</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbani MA, Mahmood MS, Mekan SF, Frossard PM (2008) Association of angiotensin-converting enzyme gene dimorphisms with severity of lupus disease. Saudi J Kidney Dis Transpl 19(5):761&#x2013;766</Citation><ArticleIdList><ArticleId IdType="pubmed">18711292</ArticleId></ArticleIdList></Reference><Reference><Citation>Topete-Reyes JF, Soto-Vargas J, Mor&#xe1;n-Moguel MC, D&#xe1;valos-Rodr&#xed;guez IP, Ch&#xe1;vez-Gonz&#xe1;lez EL, Garc&#xed;a-de la Torre I et al (2013) Insertion/deletion polymorphism of the angiotensin-converting enzyme gene in lupus nephritis among Mexicans. Immunopharmacol Immunotoxicol 35(1):174&#x2013;180. https://doi.org/10.3109/08923973.2012.739175</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08923973.2012.739175</ArticleId><ArticleId IdType="pubmed">23137230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian LH, Lau TP, Ching AS, Chua KH (2012) Angiotensin-converting enzyme gene I/D dimorphism does not play a major role in the susceptibility of Malaysian systemic lupus erythematosus patients. Genet Mol Res 11(2):863&#x2013;871. https://doi.org/10.4238/2012.April.10.2</Citation><ArticleIdList><ArticleId IdType="doi">10.4238/2012.April.10.2</ArticleId><ArticleId IdType="pubmed">22576914</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>